Cover Page

About gist

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

Review Article 
Esophageal gastrointestinal stromal tumors: a literature review
Carlo Alberto De Pasqual, Selma Hetoja, Maria Clelia Gervasi, Giovanni de Manzoni
Gastrointestinal Stromal Tumor  
2023;
6:
7  
Editorial Commentary 
Could artificial intelligence replace fine-needle aspiration in endoscopic ultrasound?
Shirley X. Jiang, Nasim Parsa, Michael F. Byrne
Gastrointestinal Stromal Tumor  
2023;
6:
6  
Editorial Commentary 
The past, present, and future: the evolving role and challenges of surgery in the multimodal management of gastrointestinal stromal tumors
Russell G. Witt, Heather G. Lyu, Emily Z. Keung
Gastrointestinal Stromal Tumor  
2023;
6:
5  
Editorial Commentary 
Avapritinib—a therapeutic breakthrough for PDGFRA D842V mutated gastrointestinal stromal tumors
Evelyne Roets, Neeltje Steeghs
Gastrointestinal Stromal Tumor  
2023;
6:
4  
Editorial Commentary 
Ripretinib inhibits polyclonal drug-resistant KIT oncoproteins: the next step forward in gastrointestinal stromal tumor therapy
Maria Debiec-Rychter, Piotr Rutkowski
Gastrointestinal Stromal Tumor  
2023;
6:
3  
Review Article 
Rectal and esophageal gastrointestinal stromal tumors—how to deal with it?—technical approach and role of neoadjuvant treatment
José M. Asencio, Luis M. Jiménez, Miguel A. Steiner
Gastrointestinal Stromal Tumor  
2023;
6:
2  
Editorial Commentary 
Dawn of immunotherapy treatment for gastrointestinal stromal tumors
Scott M. Schuetze
Gastrointestinal Stromal Tumor  
2023;
6:
1  
Editorial Commentary 
Gastrointestinal stromal tumor (GIST): molecular heterogeneity and current challenges
Amitesh C. Roy, John R. Zalcberg
Gastrointestinal Stromal Tumor  
2022;
5:
8  
Review Article 
A narrative review of minimally invasive techniques for treatment of gastric gastrointestinal stromal tumors
Paolo Pizzini, Sara Coppola, Filippo Ascari, Michele Manara, Stefano De Pascale
Gastrointestinal Stromal Tumor  
2022;
5:
7  
Original Article 
High proportion of wild-type gastrointestinal stromal tumor in a cohort of Chilean patients screened by KIT and PDGFRA exome profiling
Matías Muñoz-Medel, Miguel Córdova-Delgado, Ignacio N. Retamal, Fabián Villalobos, Rosemarie Mellado, Piga Fernández, Patricio Manque, Alejandro Berkovits, Juvenal A. Ríos, Benjamín García-Bloj, María Paz Rodríguez, Marcelo Garrido
Gastrointestinal Stromal Tumor  
2022;
5:
6  
Editorial Commentary 
Advances in therapy of succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumor
Piotr Rutkowski, Maria Debiec-Rychter
Gastrointestinal Stromal Tumor  
2022;
5:
5  
Review Article 
New molecularly targeted drugs for gist after imatinib, sunitinib and regorafenib: a narrative review
Alessandro Mazzocca, Alessandro Minelli, Flavia Paternostro, Marianna Silletta, Andrea Napolitano, Bruno Vincenzi
Gastrointestinal Stromal Tumor  
2022;
5:
4  
Review Article 
Which is the Achilles heel of gastrointestinal stromal tumour and how to use it for the future?—a review of novel therapeutic paradigms
Iván Olivares-Rivas, Alfonso García-Valverde, César Serrano
Gastrointestinal Stromal Tumor  
2022;
5:
3  
Case Report 
Primary jejunal gastrointestinal stromal tumor in a patient with phakomatosis: a case report of an uncommon source of massive gastrointestinal hemorrhage
Ramon O. Minjares, Philippos A. Costa, Diego M. Montoya-Cerrillo, Luis E. Aguirre
Gastrointestinal Stromal Tumor  
2022;
5:
2  
Case Report 
Resection of a giant gastrointestinal stromal tumor after failed imatinib treatment during the COVID-19 pandemic: a case report
Katie Yusun Kwon, Facundo Iriarte, Heather Ann Hartman, Juhi Mittal, Antonio Di Carlo, Abbas El-Sayed Abbas
Gastrointestinal Stromal Tumor  
2022;
5:
1  
Review Article 
A narrative review of imatinib-resistant gastrointestinal stromal tumors
Yujiro Hayashi, Vy Truong Thuy Nguyen
Gastrointestinal Stromal Tumor  
2021;
4:
6  
Review Article 
A narrative review of surgical management of gastrointestinal stromal tumors
Iwona Kalinowska, Marcin Zdzienicki, Jacek Skoczylas, Piotr Rutkowski
Gastrointestinal Stromal Tumor  
2021;
4:
5  
Review Article 
Adjuvant therapy for primary GIST: is longer really better? A narrative review
Pamela W. Lu, Chandrajit P. Raut
Gastrointestinal Stromal Tumor  
2021;
4:
4  
Editorial Commentary 
Design your strategy, define your costs: third or subsequent-lines in advanced gastrointestinal stromal tumors (GIST)
Jacopo Giuliani
Gastrointestinal Stromal Tumor  
2021;
4:
3  
Original Article 
Novel association between Helicobacter pylori infection and gastrointestinal stromal tumors (GIST) in a multi-ethnic population
Jaclyn Kagihara, Brent Matsuda, Kraig L. Young, Xiufen Li, Xuegang Lao, Gautam A. Deshpande, Fumio Omata, Terrilea Burnett, Charles F. Lynch, Brenda Y. Hernandez, Scott K. Kuwada
Published online: 10 November 2020
Review Article 
New molecularly targeted drugs for gist after imatinib, sunitinib and regorafenib: a narrative review
Alessandro Mazzocca, Alessandro Minelli, Flavia Paternostro, Marianna Silletta, Andrea Napolitano, Bruno Vincenzi
Published online: 30 May 2022
Review Article 
A narrative review of surgical management of gastrointestinal stromal tumors
Iwona Kalinowska, Marcin Zdzienicki, Jacek Skoczylas, Piotr Rutkowski
Published online: 30 September 2021
Editorial 
A new promising quinazoline-derived Pan-KIT mutant inhibitor for the gastrointestinal stromal tumors (GIST) management
Nathália C. Campanella, Viviane A. O. Silva, Rui Manuel Reis
Published online: 10 December 2018
Review Article 
A narrative review of imatinib-resistant gastrointestinal stromal tumors
Yujiro Hayashi, Vy Truong Thuy Nguyen
Published online: 30 October 2021
Editorial Commentary 
Advancing the promises of precision medicine for patients with gastrointestinal stromal tumor
Joaquina C. Baranda, Andrew K. Godwin
Published online: 04 December 2019
Images in Clinical Medicine 
Gastrointestinal stromal tumor with a platelet-derived growth factor receptor-alpha mutation
Tatsuo Kanda, Takashi Ishikawa, Takahiro Taguchi
Published online: 18 January 2019
Case Report 
Dose escalation of ripretinib can lead to response in advanced gastrointestinal stromal tumor patients refractory to the standard dose: a report of two cases
Philippos Apolinario Costa, Caroline Kamal Abdelmessih Hana, Navin Chakravarthy Balaji, Anthony Frank Skryd, Brianna Nicole Valdes, Ramon O. Minjares, Priscila Barreto-Coelho, Andrea P. Espejo-Freire, Muhammad O. Hakim, Emily Jonczak, Ty Subhawong, Alan Livingstone, Jonathan C. Trent, Gina Z. D'Amato
Published online: 31 May 2021
Original Article 
High proportion of wild-type gastrointestinal stromal tumor in a cohort of Chilean patients screened by KIT and PDGFRA exome profiling
Matías Muñoz-Medel, Miguel Córdova-Delgado, Ignacio N. Retamal, Fabián Villalobos, Rosemarie Mellado, Piga Fernández, Patricio Manque, Alejandro Berkovits, Juvenal A. Ríos, Benjamín García-Bloj, María Paz Rodríguez, Marcelo Garrido
Published online: 14 July 2022
Editorial Commentary 
Advances in therapy of succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumor
Piotr Rutkowski, Maria Debiec-Rychter
Published online: 05 June 2022
Currently no content available!